Clinically Proven

Mean Total Meimobian Gland Score

clinically_proven_graph1

Mean Total OSDI(Ocular Surface Disease Index) Score

clinically_proven_graph2

Clinically Proven

The TearScience® technology is based on more than 25 years of research into the causes of dry eye.

Many people with Meibomian Gland Dysfunction (MGD) and Dry Eye symptoms have now been treated with LipiFlow®, including patients in controlled feasibility studies and in a randomized, controlled, multi-center clinical trial.

The randomized, controlled trial showed statistically significant improvement, on average, for the number of Meibomian glands yielding clear liquid. This study also showed significant improvement, on average, in patient self-reported Dry Eye symptoms.

The graphs to the left refer to the results of a nine center, randomized, controlled trial conducted in 2009 showing clinically meaningful improvement in the primary endpoint, which measures Meibomian gland functionality, and the secondary endpoint of Dry Eye symptoms.